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ABSTRACT Medical image analysis studies usually require medical image datasets for training, testing and 
validation of algorithms. The need is underscored by the deep learning revolution and the dominance of 
machine learning in recent medical image analysis research. Nevertheless, due to ethical and legal constraints, 
commercial conflicts and the dependence on busy medical professionals, medical image analysis researchers 
have been described as "data starved". Due to the lack of objective criteria for sufficiency of dataset size, the 
research community implicitly sets ad-hoc standards by means of the peer review process. We hypothesize 
that peer review requires researchers to report the use of ever-increasing datasets as one condition for 
acceptance of their work to reputable publication venues. To test this hypothesis, we scanned the proceedings 
of the eminent MICCAI (Medical Image Computing and Computer-Assisted Intervention) conferences from 
2011 to 2018. From a total of 2136 articles, we focused on 907 papers involving human datasets of MRI 
(Magnetic Resonance Imaging), CT (Computed Tomography) and fMRI (functional MRI) images. For each 
modality, for each of the years 2011-2018 we calculated the average, geometric mean and median number of 
human subjects used in that year's MICCAI articles. The results corroborate the dataset growth hypothesis. 
Specifically, the annual median dataset size in MICCAI articles has grown roughly 3-10 times from 2011 to 
2018, depending on the imaging modality. Statistical analysis further supports the dataset growth hypothesis 
and reveals exponential growth of the geometric mean dataset size, with annual growth of about 21% for 
MRI, 24% for CT and 31% for fMRI. In slight analogy to Moore's law, the results can provide guidance about 
trends in the expectations of the medical image analysis community regarding dataset size. 
INDEX TERMS dataset size, human subjects, medical image analysis       
I. INTRODUCTION 
Medical image analysis is an active research field, focusing 
on computational methods for the extraction of clinically-
useful information from medical images. Research in 
medical image analysis critically depends on the availability 
of relevant medical image sets (datasets) for tasks such as 
training, testing and validation of algorithms. It is widely 
accepted that solid medical image analysis research requires 
the use of sufficiently large datasets. This notion is rooted in 
classical statistical estimation [1] and classification [2] 
theories.  
Obtaining relevant medical images is challenging and 
costly, as it requires cooperation of medical professionals 
and institutes, and alleviation of ethical, legal and often 
commercial conflicts. For example, making a clinical 
medical image available for research usually requires a 
collaborating clinical expert to obtain regulatory approvals, 
to find a relevant image in an institutional archive, to 
interpret the image and to remove identifying details. Thus, 
for research in medical image analysis, relevant images are 
usually in high demand and short supply. In a recent 
conference [3], "the common theme from attendees was that 
everyone participating in medical image evaluation with 
machine learning is data starved." Thus, typical dataset sizes 
in medical image analysis research are a far cry from the 
common perception of big data in healthcare [4]. 
Since 2012, the Deep Learning paradigm revolutionized 
the field of medical image analysis [5], underscoring the 
significance of large image datasets. Thus, researchers are 
torn between the need for large image datasets, i.e., datasets 
containing medical images of many subjects, and the cost 
and effort required to obtain them.  
In contrast to classical estimation, detection and 
classification problems, where sample size planning may 
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yield to analysis [1-2, 6-10], theoretical understanding of 
deep learning is limited. The trend is that increasing the 
training dataset size improves the performance of deep 
learning networks [11]. Small datasets are associated with 
overfitting and poor generalization performance on unseen 
data [11]. In the presence of rare pathologies, small datasets 
are known to result in class imbalance and inadequate 
training [3]. Yet, solid objective criteria for dataset size are 
difficult to obtain.  
In practice, since dataset size is associated with research 
quality, peer review processes of reputable publication 
venues implicitly set ad-hoc thresholds on dataset size. Thus, 
a manuscript is accepted for publication or presentation in a 
peer-reviewed venue only if the dataset size is regarded by 
the referees as sufficiently large. Consequently, dataset sizes 
appearing in published articles reflect the implicit standard 
for dataset size. Since the standard is not static, researchers 
are often dismayed to discover that the dataset used in their 
current study, where the number of subjects was previously 
considered sufficiently large, is no longer up to expectations. 
This uncertainty leads to marginalization and loss of 
potentially valuable research.  
The purpose of this research is to better understand the 
temporal trends in the implicit community thresholds on 
acceptable dataset size. We hypothesize that these thresholds 
grow over time, such that ever increasing datasets are 
required for acceptance of a manuscript to a reputable venue. 
Hopefully, our results will provide researchers, funding 
agencies, program committees and editors with rough 
guidelines regarding the community standards for dataset 
size in current and future medical image analysis studies.  
 
II. METHODS 
We reviewed the proceedings of the annual MICCAI 
conference from 2011 to 2018 [12-19], and noted the numbers 
of human subjects included in the datasets used. MICCAI, the 
acronym for Medical Image Computing and Computer 
Assisted Intervention, is a leading conference in the field, with 
a rigorous peer-review process (typically at least three 
reviewers, double-blind). Table 1 shows the number of 
submitted papers, the number of accepted papers (oral and 
posters) and the acceptance ratio per year (main conference 
only, excluding satellite events). We preferred monitoring a 
conference series rather than an archival journal, since the 
conference review period is much shorter than that of quality 
journals, implying a shorter sampling aperture, hence better 
temporal sampling. 
We focused on studies involving three important imaging 
modalities: Magnetic Resonance Imaging (MRI), Computed 
Tomography (CT) and Functional MRI (fMRI). Taken 
together, this selection covers a substantial portion of the 
research articles in the MICCAI proceedings. Being well-
established modalities, a good number of articles associated 
with each modality is found in each annual edition of the 
MICCAI proceedings, allowing meaningful statistical study. 
We only considered datasets referring to human subjects, 
rather than animal or other datasets. Given the stringent 
regulatory framework regarding human data [20], we believe 
that the challenges and trade-offs associated with collection 
and use of human medical data are unique and justify 
exclusion of non-human datasets from this study. 
Nevertheless, in-utero and post-mortem human datasets are 
included. We define the dataset size to be the number of 
distinct human subjects, rather than the number of test 
images or similar data structures, as the number of human 
subjects better reflects the recruitment effort.   
For each year and for each modality, we found the relevant 
articles in the MICCAI proceedings and extracted from each 
article the dataset size. No distinction was made between 
data used for training, validation, testing or any other use. 
With few exceptions, articles associated with several 
imaging modalities were considered with regard to one of the 
modalities, with preference to fMRI over CT and MRI. Table 
2 shows the number of relevant MICCAI articles, i.e. the 
articles included in our analysis, per year and imaging 
modality. The growth in 2018 corresponds to the larger overall 
number of articles in MICCAI 2018 (see Table 1). 
To obtain descriptive results (Section III), for each year 
and modality the average, geometric mean and median 
dataset sizes were calculated. In computing the average, to 
reduce the effect of outliers, the largest value and smallest 
value were discarded. 
Statistical analysis of the data (Section IV) was performed, 
for each modality separately, using SPSS v.25 and R v.3.6.0. 
p-values were corrected for multiple comparisons using the 
Benjamini-Hochberg (BH) procedure, with p<0.05 
considered significant. 
TABLE 1 
MICCAI SUBMISSION AND ACCEPTANCE DATA (MAIN CONFERENCE) 
 Submitted papers Accepted papers Acceptance rate 
2011 819 251 30% 
2012 781 252 32% 
2013 798 262 33% 
2014 862 253 29% 
2015 810 263 32% 
2016 756 228 30% 
2017 800 255 32% 
2018 1068 372 35% 
TABLE 2 
NUMBER OF ARTICLES INCLUDED IN THE ANALYSIS, PER YEAR AND 
IMAGING MODALITY 
 
2011 2012 2013 2014 2015 2016 2017 2018 
MRI 62 63 76 63 66 69 75 94 
CT 36 24 20 40 23 14 30 36 
fMRI 11 10 14 10 14 16 15 26 
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III. DESCRIPTIVE RESULTS 
For MRI, the annual average, geometric mean and median 
dataset sizes, used in MICCAI articles in each of the years 
2011-2018, are shown in Table 3. It can be seen that all three 
measures roughly trebled over the study period. The higher 
values of the average values follow from the occasional use of 
large publicly accessible datasets, see e.g. [21], affecting the 
averages but not the median values. A graphical representation 
of the median values per year is shown in Figure 1. 
The measures for CT are presented in Table 4, showing 
marked overall dataset growth over the study period. For CT, 
the graph of median dataset size per year is shown in Fig. 2. 
The corresponding data for fMRI is presented in Table 5 
and in Figure 3. The vertical scale in Figure 3 is different 
than in Figures 1 and 2, reflecting the larger growth rate. 
 
IV. STATISTICAL ANALYSIS AND PREDICTION 
As a preliminary test of the dataset growth hypothesis, we 
first divided the range of years into two categories: 2011-
2014 and 2015-2018. The distributions of the dataset sizes in 
the two categories were similar and non-normal. A Mann-
Whitney U test was carried out to determine if there were 
differences in dataset sizes between the two time categories.   
 For MRI, the median numbers of subjects for 2011-2014 
(26) and 2015-2018 (55.5) were statistically significantly 
different, U=19.115, p<0.001.  
 For CT, the median numbers of subjects for 2011-2014 
(18.5) and 2015-2018 (36) were statistically significantly 
different, U=8.311, p=0.006.  
 For fMRI, the median numbers of subjects for 2011-2014 
(37) and 2015-2018 (77) were statistically significantly 
different, U=10.493, p=0.003.  
These results corroborate the dataset-growth hypothesis.  
 
TABLE 4 
AVERAGE, GEOMETRIC MEAN AND MEDIAN CT DATASET SIZES 
(NUMBER OF SUBJECTS) USED IN MICCAI ARTICLES IN EACH OF 
THE YEARS 2011-2018  
CT 2011 2012 2013 2014 2015 2016 2017 2018 
average 54.4 26.8 40.4 48.0 71.6 71.3 143.9 504.0 
geom. mean 19.1 15.6 26.4 20.3 29.3 39.7 35.7 102.0 
median 17 16 33 20 29 24 28 72 
TABLE 3 
AVERAGE, GEOMETRIC MEAN AND MEDIAN MRI DATASET SIZES 
(NUMBER OF SUBJECTS) USED IN MICCAI ARTICLES IN EACH OF 
THE YEARS 2011-2018  
MRI 2011 2012 2013 2014 2015 2016 2017 2018 
average 74.3 52.2 79.9 139.2 65.6 163.6 178.1 250.6 
geom. mean 21.7 19.2 28.5 43.0 27.4 64.2 62.5 68.6 
median 23 20 21 54 33 64 80 67 
TABLE 5 
AVERAGE, GEOMETRIC MEAN AND MEDIAN FUNCTIONAL MRI 
DATASET SIZES (NUMBER OF SUBJECTS) USED IN MICCAI 
ARTICLES IN EACH OF THE YEARS 2011-2018  
fMRI 2011 2012 2013 2014 2015 2016 2017 2018 
average 21.3 31.9 32.3 67.5 86.6 111.7 151.6 264.4 
geom. mean 17.3 27.9 25.2 65.1 59.8 93.7 68.0 131.6 
median 15 29 25 64 53 86 46 191 
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FIGURE 3.  Median size of datasets used in MICCAI articles related to 
fMRI in each of the years 2011-2018. 
FIGURE 1.  Median size of datasets used in MICCAI articles related to MRI 
in each of the years 2011-2018. 
FIGURE 2.  Median size of datasets used in MICCAI articles related to CT 
in each of the years 2011-2018. 
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Returning to the full year range 2011-2018, we used the 
natural logarithm (ln) transformation to normalize dataset 
sizes. Linear regression established that the year (after 2010) 
can statistically significantly predict the natural logarithm of 
dataset size.  
For MRI, the model was statistically significant, 
F(1,566)=38.720, p<0.001. The model explained 6.2% 
(adjusted R2) of the variance in the natural logarithm of 
dataset sizes. The year was statistically significant (B=0.189, 
CI=[0.129,0.249], p<0.001), where B denotes slope and CI 
is its confidence interval. The regression equation is 
(ln ) = 2.771 + 0.189( − 2010)             (1) 
 
where Ê(ln N) is the predicted mean of the natural logarithm 
of dataset sizes and y is the year. Returning to the original 
scale of MRI dataset sizes, we obtain  
() = ..()                          (2)  
Here, Ĝ(N) is the predicted geometric mean of MRI dataset 
sizes. The annual growth rate of the predicted geometric 
mean is about 21%, corresponding to (e0.189 – 1). Figure 4 
shows Ĝ(N) with its confidence interval for each of the years 
2011-2019. The empirical geometric means, taken from 
Table 3, are shown for comparison, but note that the 
regression is based on the whole ensemble of MRI dataset 
sizes, not on their empirical geometric means. The prediction 
for 2019 is of special interest, since MICCAI 2019 has not 
yet taken place at the time of writing. Specifically, we predict 
the geometric mean of MRI dataset sizes in MICCAI 2019 
to be 87.5, with confidence interval [65.5,116.9].  
The regression model was statistically significant for CT 
as well, F(1,221)=21.273, p<0.001. The model explained 
8.4% (adjusted R2) of the variance in the natural logarithm 
of dataset sizes. The year was statistically significant 
(B=0.213, [CI=0.122,0.305], p<0.001). The regression 
equation is   
(ln ) = 2.456 + 0.213( − 2010)             (3) 
Returning to the original scale of CT dataset sizes, we obtain  
() = .#$%.&()                          (4)  
In Eq. (4), Ĝ(N) is the predicted geometric mean of CT 
dataset sizes. Here, the annual growth rate of the predicted 
geometric mean is about 24%. Figure 5 shows Ĝ(N) with its 
confidence interval for each of the years 2011-2019. The 
empirical geometric means, taken from Table 4, are shown 
for comparison, but note that the regression is based on the 
whole ensemble of CT dataset sizes, not on their empirical 
geometric means. We predict the geometric mean of CT 
dataset sizes in the upcoming MICCAI 2019 conference to 
be 79.6, with confidence interval [49.9,126.9]. 
Finally, for fMRI, the model was yet again statistically 
significant, F(1,114)=27.130, p<0.001. The model explained 
18.5% (adjusted R2) of the variance in the natural logarithm 
of dataset sizes. The year was statistically significant 
(B=0.271, CI=[0.168,0.374], p<0.001). The regression 
equation is   
(ln ) = 2.683 + 0.271( − 2010)             (5) 
Returning to the original scale of fMRI dataset sizes, we 
obtain  
() = .%&.()                          (6)  
In Eq. (6), Ĝ(N) is the predicted geometric mean of fMRI 
dataset sizes. For fMRI, the annual growth rate of the 
FIGURE 4.  Predicted geometric mean (black dots) and confidence 
intervals of dataset sizes in MICCAI articles involving MRI for the years 
2011-2019. The empirical geometric means (2011-2018) are shown for 
comparison (x marks), but note that the regression was based on the 
whole ensemble of MRI dataset sizes, not on the empirical geometric 
means. 
FIGURE 5.  Predicted geometric mean (black dots) and confidence 
intervals of dataset sizes in MICCAI articles involving CT for the years 
2011-2019. The empirical geometric means (2011-2018) are shown for 
comparison (x marks), but note that the regression was based on the 
whole ensemble of CT dataset sizes, not on the empirical geometric 
means. 
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predicted geometric mean is about 31%. Figure 6 shows 
Ĝ(N) with its confidence interval for each of the years 2011-
2019. The empirical geometric means, taken from Table 5, 
are shown for comparison, but note that the regression is 
based on the whole ensemble of fMRI dataset sizes, not on 
their empirical geometric means. We predict the geometric 
mean of fMRI dataset sizes in the MICCAI 2019 conference 
to be 167.7, with confidence interval [104.9,268.0]. 
 
V. CONCLUSIONS 
To our knowledge, this research is the first attempt to quantify 
the expectations of the research community regarding dataset 
size in medical image analysis research. 
We scanned all the 2136 articles published in the MICCAI 
proceedings from 2011 to 2018. We extracted the dataset sizes 
from 907 papers relying on human data from three prevalent 
imaging modalities: MRI, CT and fMRI. Tables 3-5 and Figs. 
1-3 describe the data. Human dataset size in MRI-related 
research nearly trebled from 2011 to 2018, while the CT and 
fMRI datasets grew at even faster rates. Similar trends are 
observed in the median, geometric mean and average values, 
though the average numbers are substantially higher than the 
median and geometric mean measures due to the occasional 
use of very large open datasets. 
Statistical analysis using the Mann-Whitney U test 
corroborates the dataset growth hypothesis for all three 
modalities. Furthermore, regression analysis reveals 
statistically significant exponential growth in the geometric 
mean of the dataset sizes, albeit with large variability. The 
predicted annual growth rates in the geometric mean of the 
number of subjects in the datasets are about 21% for MRI, 
24% for CT and 31% for fMRI. In slight analogy to Moore's 
law, these estimated growth rates can provide researchers, 
review boards and funding agencies with a tentative roadmap 
regarding dataset sizes in future medical image analysis 
studies. 
In the upcoming MICCAI 2019 conference, we predict the 
geometric mean of the number of subjects in the datasets to be 
87.5 with confidence interval [65.5,116.9] for MRI related 
articles, 79.6, with confidence interval [49.9,126.9] for CT and 
167.7 with confidence interval [104.9,268.0] for fMRI.  
The perception that "everyone participating in medical 
image evaluation with machine learning is data starved" [3] 
is not surprising given the exponentially increasing 
expectations regarding dataset size. Transfer learning [22] 
and data augmentation [23] are two popular and often 
successful strategies to alleviate the shortage of data, see 
[24]. Recently, Generative Adversarial Networks (GAN) 
have been used to create large sets of "fake" but credible new 
medical images based on a limited collection of genuine 
images, see e.g. [25]. If accepted by the research community, 
this strategy may bridge the gap between demand and supply 
of medical images for use in research and development. 
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